The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Ragosa Mark

Reporting owner CIK 0001835458 · CHIEF FINANCIAL OFFICER

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Ragosa MarkRagosa MarkRagosa Mark · December 8, 2025 · Exercise / conversion · Class A Ordinary ShareRagosa Mark · December 8, 2025 · Exercise / conversion · Class A Ordinary ShareRagosa Mark · December 8, 2025 · Exercise / conversion · Class A Ordinary ShareRagosa Mark · November 12, 2025 · Exercise / conversion · Class A Ordinary ShareRagosa Mark · October 28, 2025 · Exercise / conversion · Class A Ordinary ShareOct 28, 2025Dec 8, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 8, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareRagosa MarkExercise / conversion
Dec 8, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareRagosa MarkExercise / conversion
Dec 8, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareRagosa MarkExercise / conversion
Nov 12, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareRagosa MarkExercise / conversion
Oct 28, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareRagosa MarkExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M10,51210.76Value: 113,109.12Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M16,16511.97Value: 193,495.05Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M16,16411.1Value: 179,420.4Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M19,90030.93Value: 615,507Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M10030.93Value: 3,093Currency not specifiedView ↗